By Susane Fanning, Research Content Lead. Susane covers peptide research literature, regulatory filings, and analytical testing standards for laboratory supply audiences. Fact-checked by Dino Ryan, Editor.

The Wolverine Stack pairs two lab-made peptides, BPC-157 and TB-500, sold as research materials and studied for how tissue repairs itself. Neither one is FDA-approved for use in humans or animals, and the stack has no set formula.

BPC-157 is a 15-amino-acid chain based on a stomach protein, and it shows up in research on how tissue recovers. TB-500 is a seven-amino-acid piece of a protein called thymosin beta-4, and researchers study it for how cells move and how new blood vessels form. Both appear in repair research, but they approach it from different angles.

Interest in the stack has climbed fast, from about 550 US searches a month in August 2023 to roughly 8,657 in August 2026. 

This article covers what the research so far backs up about the Wolverine Peptide Stack, what hasn’t been tested yet, and how to read the certificate of analysis on a research vial.

Wolverine Stack at a Glance

Why Is It Called the Wolverine Stack?

The name came from the internet. Somebody on a bodybuilding forum noticed both BPC-157 and TB-500 were being talked about for tissue repair, paired them together, and reached for the most obvious pop-culture shorthand available: the X-Men mutant who regrows whatever gets damaged. It stuck, because it’s catchy.

Then it snowballed. Podcast mentions, clinic marketing pages, and vendor SEO all picked up the same phrase, and now it’s the search term. Our Ahrefs data shows “bpc 157 and tb 500” jumping 93% in a single month, from about 5,008 searches in December 2025 to 9,642 in January 2026, as coverage of the compounds went mainstream.

The nickname carries an implied claim. Wolverine heals instantly and completely. Naming a research pairing after him borrows that concept. 

What Is Actually in a Wolverine Stack?

There’s no standard recipe. Most sellers list two compounds:

• BPC-157, a synthetic 15-amino-acid sequence that stands for Body Protection Compound. It’s usually supplied as a lyophilized powder for reconstitution in a laboratory setting.
• TB-500 is a seven-residue piece of Thymosin Beta-4, a 43-amino-acid protein. 

Some clinics may sell a four-compound “Wolverine Stack” that adds CJC-1295 and Ipamorelin, two growth-hormone secretagogues with completely different mechanisms. Others may sell oral versions or blended single vials.

The problem with blends is that ratios don’t stay consistent across vendors. One sells 5mg of each compound; another ships 10mg of one and 2mg of the other. Plus, once they’re pre-mixed, you’ve lost the ability to run either compound on its own.

The Wolverine Stack by Research Objective

Lumping the entire stack under a “recovery” function hides what these compounds are actually studied for. Here’s what research says: 

Tissue-Repair Research

BPC-157 dominates tissue-repair research in rodents. The published work reports outcomes in models of tendon, muscle, and gut tissue damage, with proposed mechanisms involving angiogenesis, nitric oxide signaling, and changes in growth factor receptor expression.

The doses in the literature surprise people. A 2021 review in Frontiers in Pharmacology reports the research group using “10 μg, 10 ng, and 10 pg/kg” in rat models, given intraperitoneally once daily, in drinking water, or as a 1 μg/g topical cream.

Connective-Tissue And Cellular-Migration Research

TB-500’s proposed mechanism is actin binding, which in theory influences cell migration to a damage site, angiogenesis, and extracellular matrix remodeling. However, most of this work studied full-length thymosin beta-4 protein, which may or may not apply to the seven-residue fragment sold as TB-500. 

Growth-Hormone And IGF-1 Research

CJC-1295 and Ipamorelin are growth-hormone secretagogues, and some vendors add them to the wolverine stack. Research asks whether they prompt the pituitary to release growth hormone, which in turn raises circulating IGF-1.

IGF-1 is studied as a driver of collagen synthesis and fibroblast activity, the same repair endpoints BPC-157 and TB-500 research targets locally. The GH axis covers the systemic version of that question. 

Muscle-Preservation Research

Injured people stop using the injured limb/part. The surrounding muscle shrinks, which doctors call disuse atrophy. That shrinkage happens during the same weeks of repair, so two processes often end up in the same conversation. The muscle-related research in the Wolverine stack belongs to CJC-1295 and Ipamorelin. 

Why Researchers Might Study These Mechanisms Together

Researchers study BPC-157 for what happens right at the damaged site and TB-500 for cell migration to wounds and new blood vessel formation. CJC-1295 and Ipamorelin are studied for the body’s hormone supply that supports tissue building throughout the body.

Picture a repair crew, the roads that get them to the site, and the depot that stocks their materials. On paper, the three jobs don’t overlap, but they complement each other. The stack borrows the same concept, with its components addressing different parts of the same process. 

Wolverine Stack: What the Evidence Actually Supports

Wolverine Stack vs. Taking the Compounds Individually

Tissue repair depends on two things: 

1. Blood supply and growth signaling reaching the damaged site
2. Reparative cells physically migrate into it. 

BPC-157 acts on the first through nitric oxide and growth-factor signaling, promoting new vessel formation. TB-500 acts on the second through actin regulation, the machinery that lets cells migrate. When you run the pair together, you cover both pathways and investigate a broader protocol. However, the results are difficult to attribute to one compound. 

Wolverine Stack Vs Individual Compounds

What Researchers Should Look for When Evaluating a Wolverine Stack

Matthew Fedoruk, Chief Science Officer at the U.S. Anti-Doping Agency, put the risk of buying gray market stacks bluntly: “You don’t even know what you’re buying inside that bottle. It could be a peptide. It could be a steroid. It could be something just like water.”

To ensure legitimacy, evaluate your options through our 8-point COA check:

• Compound identity: The label should name the exact compound and, for fragments, the actual sequence. 
• Purity: A stated purity figure with a threshold, such as ≥99%, plus the actual measured number for your lot.
• Analytical testing: HPLC measures purity. LC-MS confirms identity. Purity without identity means you know how clean it is, but not what it is.
• Lot-specific COA: The certificate must carry the same lot number printed on the vial in your hand.
• Sterility and endotoxin testing: Where applicable, look for USP <71> sterility and USP <85> bacterial endotoxin results.
• Storage information: Documented storage conditions for the lyophilized powder and for reconstituted solution.
• Batch consistency: Evidence that lots are tested against each other, so lot 12 behaves like lot 3.
• Independent laboratory verification: Testing performed by an accredited third-party laboratory, with the accreditation stated on the certificate.

Safety Profile and Research Limitations

The real limitations are structural. Here’s what’s actually unknown: 

Known Limitations Of The Individual Compounds

The FDA has stated its concerns in writing. On its list of bulk drug substances that may present significant safety risks, the agency notes that compounded drugs containing BPC-157 “may pose risk for immunogenicity for certain routes of administration and may have complexities about peptide-related impurities.” It flags the thymosin beta-4 fragment for “potential for aggregation.” Both of those are manufacturing and quality concerns, varying by vendors.

Unknowns Surrounding Combinations

Since no study has tested the two compounds together, there is no interaction data. Nobody has measured whether they compete, amplify, cancel out, or do nothing to each other. A combination safety profile requires a combination study, and that study has not been run.

Why Animal or Mechanistic Findings Cannot Be Treated As Clinical Outcomes

Rodent results are a starting point for a research program. Conclusions about people require human data, and that is missing. Doses in the published rat literature are expressed per kilogram of rat, across a range spanning micrograms to picograms. The authors do not account for species differences in metabolism, absorption, and receptor expression. 

USADA states there are “no human clinical trials establishing efficacy for the use of BPC-157 for any diagnosis or treatment,” and classifies it under S0, Non-Approved Substances.

Research-Use-Only Considerations

These compounds are currently supplied for laboratory and research purposes. They are not FDA-approved. They are also prohibited in competitive sport. Only qualified professionals in controlled laboratory environments can legally handle, store, and apply them.

Common Misconceptions About the Wolverine Stack

Misconception: “More peptides means better results.”

Reality: More peptides in a stack let you investigate a broader protocol than individual compounds ever could. Whether the results are better still needs testing. 

This argues for the stack, not against it. Two compounds, chosen to cover different stages of repair. 

Misconception: “The BPC-157 literature proves the stack works.”

Reality: The preclinical literature on BPC-157 is promising. But the stack needs its own human study to prove both compounds work as a team, and that doesn’t exist yet. 

Misconception: “A high-purity COA proves effectiveness.”

Reality: A COA confirms identity and purity, assays that tell you the vial you bought is legit. Proof of effectiveness comes from research studies around the compounds. 

Misconception: “Animal studies establish human results.”

Reality: Animal studies open the door to further research in humans. They don’t guarantee the same outcomes in both species. 

Misconception: “The Wolverine Stack is a standardized formulation.”

Reality: Wolverine stack formulation varies by vendors. Most keep TB-500 and BPC-157 as the only components. Some may add Ipamorelin and CJC-1295 as well. 

How to Evaluate Research-Grade Peptide Quality

Ask this one question: can you trace every claim on the label back to a document about your specific vial? 

Look for a certificate that carries your vial’s own lot number. Look for the assay method named, so you know whether they confirmed identity or only measured purity. Look for the actual measured figure, published as it came off the instrument. And look for accreditation, because ISO/IEC 17025 lets a laboratory “demonstrate that they operate competently and generate valid results.”

Kylo Peptides offers a reasonable example of what COA documentation should look like in practice. It runs every batch through seven assays: 

1. Sterility (USP <71>)
2. Endotoxin (USP <85>)
3. HPLC-UV purity
4. LC-MS identity
5. ICP-MS heavy metals
6. Net content verification
7. Batch consistency. 

Where to Buy Wolverine Stack for Research?

Compare vendors on what they publish per lot, then on cost. Kylo’s Wolverine Stack is listed as a two-vial research set of BPC-157 and TB-500 at 5mg each, lyophilized and sealed individually. They are supplied at ≥99% purity by HPLC, with a lot-matched Certificate of Analysis published on the website, testing across seven assays from 3 independent ISO labs. 

Storage guidance is specific: store the lyophilized powder sealed, dry, and away from light at -20 °C; after reconstitution, keep the solution at 2 to 8 °C.

The set is listed at $139.95, with free shipping on US orders over $200, same-day dispatch on orders placed before 2 PM, and a 30-day money-back guarantee. All products are supplied strictly for laboratory and research use.

Frequently Asked Questions

What is the Wolverine Stack? 

The Wolverine Stack is an informal name for pairing two research peptides, BPC-157 and TB-500, sold and discussed together. The term started as a nickname in online communities. No regulatory body has recognized, defined, or standardized it yet.

What peptides are commonly associated with it? 

BPC-157 and TB-500 form the base pair. Some vendors and clinics add CJC-1295 and Ipamorelin, two growth-hormone secretagogues, producing a four-compound version. Contents vary by seller, so check the label on the box you’re actually buying.

Why are BPC-157 and TB-500 discussed together? 

BPC-157 research focuses on local tissue repair. TB-500 research focuses on cell migration and angiogenesis. The idea is that the pathways are complementary and worth testing. 

Does research show the complete stack works better than individual compounds? 

No published study has tested BPC-157 and TB-500 together in any species, so there is no comparison data. Claims that the combination outperforms either compound alone have no published basis.

Has the Wolverine Stack been clinically studied? 

The combination has not. A Phase 2 placebo-controlled trial of BPC-157 alone is registered on ClinicalTrials.gov as NCT07437547, “BPC 157 for Acute Hamstring Muscle Strain Repair,” sponsored by Hudson Biotech with 120 participants planned.

Is the Wolverine Stack FDA-approved? 

No. Neither BPC-157 nor TB-500 is FDA-approved for human or veterinary use. In briefing materials for its July 2026 Pharmacy Compounding Advisory Committee meeting, the FDA proposed that both substances “NOT be included on the 503A Bulks List.”

What should a research-grade COA contain? 

A lot number matching the vial, the compound’s full identity, the assay methods used, the measured purity figure, sterility and endotoxin results where applicable, the testing date, and the laboratory’s accreditation. A certificate that doesn’t name your specific lot isn’t documenting your vial.

Are all Wolverine Stack formulations identical?

No. Some are two vials, some are four compounds including GH secretagogues, some are pre-blended, and quantities differ across vendors. Two products carrying the same name can contain different compounds at different strengths.

Final Thoughts

The Wolverine stack gives you two research compounds: BPC-157 and TB-500 stacked together in separate vials. The pairing makes sense as both are studied for repair. BPC-157 studies focus on tendon, ligament, and tissue recovery in rodent models. TB-500 studies discuss cell migration and angiogenesis. 

If you’re sourcing these compounds for lab work, start by asking what the paperwork proves. Run our 8-point COA check to sort a reliable vendor. If you want to skip the homework, Kylo Peptides, which we personally analyzed, can be a good start. 

Disclaimer: This article is for informational purposes and covers laboratory research materials. It does not constitute medical advice and does not describe human use. The U.S. Food and Drug Administration does not approve the compounds discussed for human or veterinary use. Consult a qualified professional before making health decisions.

Stay updated, free articles. Join our Telegram channel

Join